Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Assets (2016 - 2025)

Standard Biotools (LAB) has disclosed Current Assets for 16 consecutive years, with $472.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 4.15% to $472.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $472.4 million, a 4.15% increase, with the full-year FY2024 number at $375.9 million, up 137.58% from a year prior.
  • Current Assets was $472.4 million for Q3 2025 at Standard Biotools, down from $506.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $547.6 million in Q1 2024 to a low of $72.1 million in Q4 2021.
  • A 5-year average of $261.5 million and a median of $208.8 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: tumbled 40.11% in 2021, then soared 220.79% in 2022.
  • Standard Biotools' Current Assets stood at $72.1 million in 2021, then skyrocketed by 189.76% to $208.8 million in 2022, then dropped by 24.23% to $158.2 million in 2023, then surged by 137.58% to $375.9 million in 2024, then increased by 25.69% to $472.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Current Assets are $472.4 million (Q3 2025), $506.0 million (Q2 2025), and $344.0 million (Q1 2025).